The company has not filed an annual or quarterly report since its Q3 FY2022 10-Q, filed Nov 14, 2022. Its latest SEC filing is a SC 13G/A from Feb 12, 2024.
10-Q for Q3 FY2022, filed Nov 14, 2022
The sections below describe the company as of the FY2021 annual report.
Seeks a merger or similar business combination with a business, focusing on healthcare and medical technology targets.
10-K for FY2021, filed Mar 31, 2022We are a blank check company incorporated in November 2020 as a Cayman Islands exempted company incorporated for the purpose of effecting…View ↗
While we may pursue an initial business combination opportunity in any industry or geographical location, since our initial public…View ↗
While we may acquire a business in any industry, our focus has been on the healthcare industry in the United States and other developed…View ↗
No revenue was reported.
10-K for FY2021, filed Mar 31, 2022
10-Q for Q3 FY2022, filed Nov 14, 2022
$382.8KView ↗
8-K, filed Feb 13, 2023
On February 13, 2023, Medicus Sciences Acquisition Corp. (the “Company”) issued a press release announcing that due to the Company’s…View ↗
8-K, filed Jan 18, 2023
On January 11, 2023, Medicus Sciences Acquisition Corp. (“Medicus” or the “Company”), received a notice (the “Notice”) of failure to…View ↗
Loading...
